Degludec Insulin Use in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Diabetes MellitusCritical IllnessHyperglycemia
Interventions
DRUG

Degludec insulin

"Enrolled patients will be initiated on regular insulin sliding scale (ISS) every 6 hours, administrated subcutaneously at 0600, 1200, 1800 and 2400 in patients who are nil per os and on intravenous fluid or parenteral nutrition or continuous tube feeding, according to King Faisal Specialist Hospital \& Research Center (KFSH\&RC) protocol.~Patients with two capillary point of care glucose levels of \> 10 mmol/L (180 mg/dl) will be initiated on insulin degludec at dose of 0.2 units/ kg.~Dose adjustments will be carried out on daily basis based on blood glucose levels following a written protocol."

Trial Locations (1)

Unknown

King Faisal Specialist Hospital & Research Centre, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT06056167 - Degludec Insulin Use in Critically Ill Patients | Biotech Hunter | Biotech Hunter